The role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: A review of literature
Background: Mucous membrane pemphigoid (MMP) is considered an autoimmune blistering disease that predominantly affects mucous membranes. Various treatments are available for controlling the diseases, but not all of them may respond. Materials and Methods: PubMed and Google Scholar were searched for...
Main Author: | Soheil Tavakolpour |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Journal of Research in Medical Sciences |
Subjects: | |
Online Access: | http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2016;volume=21;issue=1;spage=37;epage=37;aulast=Tavakolpour |
Similar Items
-
Mucous membrane pemphigoid affecting the epiglottis and response to intravenous immunoglobulin therapy
by: Anes Yang, et al.
Published: (2018-03-01) -
Coexistence of mucous membrane pemphigoid and vitiligo
by: Sanath Aithal, et al.
Published: (2014-01-01) -
Tracheotomy avoided in laryngeal mucous membrane pemphigoid treated with rituximab
by: Daniela A. Brake, et al.
Published: (2020-06-01) -
A Retrospective Study of Patient-Reported Data of Bullous Pemphigoid and Mucous Membrane Pemphigoid From a US-Based Registry
by: Janet Lee, et al.
Published: (2019-09-01) -
Tofacitinib for refractory ocular mucous membrane pemphigoid
by: Hayley James, et al.
Published: (2021-06-01)